Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Joly

Showing results (181-190 of 227) with videos related to

Pageof 23
Sort By:
Archives of Dermatology|June 22, 2005
Prediction of survival for patients with bullous pemphigoid: a prospective studyPascal Joly, Jacques Benichou, Catherine Lok, et al.
Journal of the American Academy of Dermatology|September 28, 2023
Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national studySokounthie Ou, Emmanuelle Tancrède-Bohin, Marina Alexandre, et al.
JAMA Dermatology|March 21, 2014
Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in FranceFlorent Grange, Pascal Joly, Coralie Barbe, et al.
JAMA Dermatology|February 5, 2025
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse PredictorsVivien Hébert, Sami Hamwi, Emmanuelle Tancrède-Bohin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 27, 2026
Tocilizumab for severe and refractory mucous membrane pemphigoidBillal Tedbirt, Maud Maho-Vaillant, Julie Gueudry, et al.
The New England Journal of Medicine|August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigusPascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
The Journal of Investigative Dermatology|September 22, 2018
Incidence and Mortality of Pemphigus in FranceLamia Jelti, Nadège Cordel, André Gillibert, et al.
American Journal of Clinical Pathology|June 29, 2005
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a reviewTony Petrella, Martine Bagot, Rein Willemze, et al.
The Journal of Investigative Dermatology|May 9, 2017
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel SequencingSylvain Mareschal, Anne Pham-Ledard, Pierre Julien Viailly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2019
The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult DermatomyositisAudrey Aussy, Manuel Fréret, Laure Gallay, et al.
Pageof 23

Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
Archives of Dermatology|June 22, 2005
Prediction of survival for patients with bullous pemphigoid: a prospective studyPascal Joly, Jacques Benichou, Catherine Lok, et al.
Journal of the American Academy of Dermatology|September 28, 2023
Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national studySokounthie Ou, Emmanuelle Tancrède-Bohin, Marina Alexandre, et al.
JAMA Dermatology|March 21, 2014
Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in FranceFlorent Grange, Pascal Joly, Coralie Barbe, et al.
JAMA Dermatology|February 5, 2025
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse PredictorsVivien Hébert, Sami Hamwi, Emmanuelle Tancrède-Bohin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 27, 2026
Tocilizumab for severe and refractory mucous membrane pemphigoidBillal Tedbirt, Maud Maho-Vaillant, Julie Gueudry, et al.
The New England Journal of Medicine|August 10, 2007
A single cycle of rituximab for the treatment of severe pemphigusPascal Joly, Hugo Mouquet, Jean-Claude Roujeau, et al.
The Journal of Investigative Dermatology|September 22, 2018
Incidence and Mortality of Pemphigus in FranceLamia Jelti, Nadège Cordel, André Gillibert, et al.
American Journal of Clinical Pathology|June 29, 2005
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a reviewTony Petrella, Martine Bagot, Rein Willemze, et al.
The Journal of Investigative Dermatology|May 9, 2017
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel SequencingSylvain Mareschal, Anne Pham-Ledard, Pierre Julien Viailly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2019
The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult DermatomyositisAudrey Aussy, Manuel Fréret, Laure Gallay, et al.
Pageof 23